Cadonilimab in advanced cervical cancer: the COMPASSION-16 trial - Authors' reply.
Saved in:
| Title: | Cadonilimab in advanced cervical cancer: the COMPASSION-16 trial - Authors' reply. |
|---|---|
| Authors: | Liu T; Akeso Biopharma, Zhongshan, China., Lu D; Akeso Biopharma, Zhongshan, China., Wu X; Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China. Electronic address: wu.xh@fudan.edu.cn. |
| Source: | Lancet (London, England) [Lancet] 2025 Aug 02; Vol. 406 (10502), pp. 446. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40752907 AccessLevel: 2 PubType: Editorial & Opinion PubTypeId: editorialOpinion PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Cadonilimab in advanced cervical cancer: the COMPASSION-16 trial - Authors' reply. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Liu+T%22">Liu T</searchLink>; Akeso Biopharma, Zhongshan, China.<br /><searchLink fieldCode="AU" term="%22Lu+D%22">Lu D</searchLink>; Akeso Biopharma, Zhongshan, China.<br /><searchLink fieldCode="AU" term="%22Wu+X%22">Wu X</searchLink>; Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China. Electronic address: wu.xh@fudan.edu.cn. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%222985213R%22">Lancet (London, England)</searchLink> [Lancet] 2025 Aug 02; Vol. 406 (10502), pp. 446. – Name: TypePub Label: Publication Type Group: TypPub Data: Letter – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>2985213R <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-547X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201406736%22">01406736 </searchLink><i>NLM ISO Abbreviation: </i>Lancet <i>Subsets: </i>MEDLINE; In Process |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40752907 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S0140-6736(25)01228-0 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 446 Titles: – TitleFull: Cadonilimab in advanced cervical cancer: the COMPASSION-16 trial - Authors' reply. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Liu T – PersonEntity: Name: NameFull: Lu D – PersonEntity: Name: NameFull: Wu X IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 08 Text: 2025 Aug 02 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1474-547X Numbering: – Type: volume Value: 406 – Type: issue Value: 10502 Titles: – TitleFull: Lancet (London, England) Type: main |
| ResultId | 1 |